US Patent Issued to The McLean Hospital on March 3 for "Human periventricular endothelial cell therapy for neuropsychiatric disorders" (Massachusetts Inventor)

ALEXANDRIA, Va., March 3 -- United States Patent no. 12,564,610, issued on March 3, was assigned to The McLean Hospital Corp. (Belmont, Mass.).

"Human periventricular endothelial cell therapy for neuropsychiatric disorders" was invented by Anju Vasudevan (Waltham, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are methods for generating human forebrain endothelial cells, compositions comprising the cells, and methods of use thereof in therapy. Provided herein are methods for generation of human embryonic forebrain-like endothelial cells (e.g., periventricular endothelial cells) from human embryonic stem cells; the methods include addition or GABA and WNT7A for efficient differentiation...